Published in J Heart Lung Transplant on July 01, 2009
Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. J Am Coll Cardiol (2014) 1.00
Ventricular arrhythmias after left ventricular assist device. Circ Arrhythm Electrophysiol (2013) 0.98
Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. J Card Fail (2011) 0.89
Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. J Thorac Cardiovasc Surg (2012) 0.88
Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator. J Interv Card Electrophysiol (2013) 0.80
Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacol Ther (2012) 0.80
Catheter ablation of ventricular tachycardia in patients with post-infarction cardiomyopathy. Korean Circ J (2014) 0.79
The Burden of Ventricular Arrhythmias Following Left Ventricular Assist Device Implantation. Arrhythm Electrophysiol Rev (2014) 0.78
Mechanical circulatory support: devices, outcomes and complications. Heart Fail Rev (2013) 0.78
Medical management of patients with continuous-flow left ventricular assist devices. Curr Treat Options Cardiovasc Med (2014) 0.76
Hemodynamic deterioration precedes onset of ventricular tachyarrhythmia after Heartmate II implantation. J Cardiothorac Surg (2016) 0.75
Critical Care Transthoracic Echocardiography: Atrial Sinus Rhythm During Ventricular Fibrillation. J Investig Med High Impact Case Rep (2014) 0.75
Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med (2013) 20.70
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation (2005) 2.81
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol (2011) 2.29
Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar). Eur Heart J (2012) 2.21
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens (2006) 2.03
Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study. Eur J Heart Fail (2014) 1.99
Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure. Eur J Heart Fail (2014) 1.60
Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant (2010) 1.53
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol (2009) 1.51
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens (2008) 1.45
High mortality among heart failure patients treated with antidepressants. Int J Cardiol (2010) 1.42
[The Mechanical Heart--HeartMate 1--Danish results]. Ugeskr Laeger (2007) 1.40
[Cardiac transplantation]. Ugeskr Laeger (2013) 1.40
Paroxysmal atrial fibrillation is uncommon in outpatients with chronic heart failure. Scand Cardiovasc J (2008) 1.40
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]. Ugeskr Laeger (2004) 1.38
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension (2005) 1.31
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J (2007) 1.30
Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol (2005) 1.12
Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. Clin Sci (Lond) (2002) 1.09
Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant (2012) 1.08
Muscle activation during selected strength exercises in women with chronic neck muscle pain. Phys Ther (2008) 1.07
Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept (2005) 1.06
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail (2004) 1.05
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol (2010) 1.04
Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Heart Fail (2011) 1.02
Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure. Eur J Heart Fail (2011) 1.00
Long-term clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J (2007) 0.99
Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J (2010) 0.98
Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. Eur J Heart Fail (2006) 0.94
An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J (2002) 0.93
Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease. J Heart Lung Transplant (2012) 0.92
Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transplant (2008) 0.92
Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail (2006) 0.91
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. Cardiovasc Drugs Ther (2005) 0.90
Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol (1985) (2005) 0.90
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study. BMJ (2003) 0.90
Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure. Cardiovasc Drugs Ther (2008) 0.90
Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial. Circulation (2013) 0.89
B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock. J Card Fail (2007) 0.89
Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients. Clin Chem (2007) 0.88
Prognostic threshold levels of NT-proBNP testing in primary care. Eur Heart J (2008) 0.87
Three decades of heart transplantation in Scandinavia: long-term follow-up. Eur J Heart Fail (2012) 0.87
Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care. Eur J Heart Fail (2013) 0.86
Risk stratification in emergency patients by copeptin. BMC Med (2014) 0.86
Primary cardiac tumors: a clinicopathologic evaluation of four cases. Cardiovasc Pathol (2010) 0.86
Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study). Eur J Heart Fail (2013) 0.85
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison. Cardiology (2004) 0.85
Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis. Eur J Heart Fail (2008) 0.85
The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure. Am Heart J (2007) 0.84
Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure. Am J Cardiol (2012) 0.84
Effects of a nurse-based heart failure clinic on drug utilization and admissions in a community hospital setting. Scand Cardiovasc J (2005) 0.84
A model of physical factors in the structural adaptation of microvascular networks in normotension and hypertension. Physiol Meas (2003) 0.84
Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction. Eur J Heart Fail (2012) 0.84
Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses. J Card Fail (2012) 0.83
The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail (2009) 0.83
Tertiary centres have improved survival compared to other hospitals in the Copenhagen area after out-of-hospital cardiac arrest. Resuscitation (2012) 0.83
Nationwide fluoroscopic screening of recalled Riata defibrillator leads in Denmark. Heart Rhythm (2013) 0.82
Constrictive pericarditis in a contemporary Danish cohort: aetiology and outcome. Scand Cardiovasc J (2015) 0.81
Hemodynamic stress echocardiography in patients supported with a continuous-flow left ventricular assist device. JACC Cardiovasc Imaging (2010) 0.81
Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure. Growth Horm IGF Res (2009) 0.81
Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: a long term follow-up study. Int J Cardiol (2013) 0.81
Effects of large conductance Ca(2+)-activated K(+) channels on nitroglycerin-mediated vasorelaxation in humans. Eur J Pharmacol (2002) 0.81
Interleukin-2 receptor antagonists as induction therapy after heart transplantation: systematic review with meta-analysis of randomized trials. J Heart Lung Transplant (2008) 0.81
Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J Heart Lung Transplant (2004) 0.81
Central and peripheral blood flow during exercise with a continuous-flow left ventricular assist device: constant versus increasing pump speed: a pilot study. Circ Heart Fail (2011) 0.81
ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study. BMJ Open (2013) 0.80
The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab. J Heart Lung Transplant (2006) 0.80
Local electric stimulation causes conducted calcium response in rat interlobular arteries. Am J Physiol Renal Physiol (2002) 0.80
Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil. Clin Respir J (2009) 0.80
Plasma YKL-40 levels are elevated in patients with chronic heart failure. Scand Cardiovasc J (2010) 0.80
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies. J Heart Lung Transplant (2012) 0.80
Troponin T is a strong marker of mortality in hospitalized patients. Int J Cardiol (2012) 0.79
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study. Int J Cardiol (2006) 0.79
Exercise-induced changes in left ventricular filling pressure after myocardial infarction assessed with simultaneous right heart catheterization and Doppler echocardiography. Int J Cardiol (2013) 0.79
Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome. Scand Cardiovasc J (2011) 0.79
Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure. Circ Heart Fail (2013) 0.79
Wall motion index, estimated glomerular filtration rate and mortality risk in patients with heart failure or myocardial infarction: a pooled analysis of 18,010 patients. Eur J Heart Fail (2008) 0.78
Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure. Congest Heart Fail (2012) 0.78
Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study. Am Heart J (2008) 0.78
Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF. Eur J Clin Invest (2011) 0.78
Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction. Circ Heart Fail (2012) 0.78
Prevalence and characteristics of diabetic patients in a chronic heart failure population. Int J Cardiol (2005) 0.78
Effect of extended follow-up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study. Eur J Heart Fail (2014) 0.78
Nitroglycerin tolerance: different mechanisms in vascular segments with or without intact endothelial function. J Cardiovasc Pharmacol (2002) 0.78
Measurement of pro-C-type natriuretic peptide in plasma. Clin Chem (2005) 0.78
Prevalence and characteristics of heart failure clinics in Denmark--design of the Danish heart failure clinics network. Eur J Heart Fail (2005) 0.78
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes. Eur J Heart Fail (2008) 0.78
Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection. J Heart Lung Transplant (2005) 0.78